Topic · page 99 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 3,921–3,960 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

Diabet Med8 Jul 2023
Do patients with prediabetes managed with metformin achieve better glycaemic control? A national study using primary care medical records
Cohort study
Int J Obes (Lond)7 Jul 2023
Acylated- and unacylated ghrelin during an oral glucose tolerance test in humans at risk for type 2 diabetes mellitus
Cross-sectional study
J Clin Endocrinol Metab7 Jul 2023
Microvascular Complications Are Associated With Coronary Collateralization in Type 2 Diabetes and Chronic Occlusion
Cohort study
Diabetes Obes Metab7 Jul 2023
Overall and inter‐individual effect of four different drug classes on soluble urokinase plasminogen activator receptor in type 1 and type 2 diabetes
Secondary analysis
Diabetes Obes Metab7 Jul 2023
Relationship between the magnitude of body mass index reductions and remission in patients with type 2 diabetes in real world settings: Analysis of nationwide patient registry in Japan ( JDDM 74)
Cohort study
Endocr Pract7 Jul 2023
Trends and Gaps in Statin Use for Cardiovascular Disease Prevention in Type 2 Diabetes: A Real-World Study in Shanghai, China
Cohort study
Diabetes Res Clin Pract7 Jul 2023
Associations of updated cardiovascular health metrics, including sleep health, with incident diabetes and cardiovascular events in older adults with prediabetes: A nationwide population-based cohort study
Cohort study
Diabetes Res Clin Pract7 Jul 2023
Association of physical activity with total and cause-specific mortality in patients with diabetes: A nationwide population-based cohort study
Cohort study
Cardiovasc Diabetol6 Jul 2023
Both LDL and HDL particle concentrations associate positively with an increased risk of developing microvascular complications in patients with type 2 diabetes: lost protection by HDL (Zodiac-63)
Cohort study
Cardiovasc Diabetol6 Jul 2023
Visit-to-visit HbA1c variability is associated with aortic stiffness progression in participants with type 2 diabetes
Cohort study
Diabetes Obes Metab6 Jul 2023
Cost‐effectiveness of canagliflozin and dapagliflozin for treatment of patients with chronic kidney disease and type 2 diabetes
Research article
Diabetes Obes Metab6 Jul 2023
Bexagliflozin as an adjunct to metformin for the treatment of type 2 diabetes in adults: A 24‐week, randomized, double‐blind, placebo‐controlled trial
Randomized controlled trial
Diabetes Res Clin Pract6 Jul 2023
Glycemic status and its association with retinal age gap: Insights from the UK biobank study
Cross-sectional study
Diabet Med6 Jul 2023
Recommendations from DiabetesUK's 2022 diabetes and physical activity workshop
Guideline or statement
Diabetes Res Clin Pract5 Jul 2023
Prevalence and prognostic impact of stress-induced hyperglycemia in patients with acute type A aortic dissection
Cohort study
Diabetes Res Clin Pract5 Jul 2023
The acute effects of a DASH diet and whole food, plant-based diet on insulin requirements and related cardiometabolic markers in individuals with insulin-treated type 2 diabetes
Research article
J Clin Endocrinol Metab5 Jul 2023
DI/cle, a Measure Consisting of Insulin Sensitivity, Secretion, and Clearance, Captures Diabetic States
Mechanistic study
Cardiovasc Diabetol5 Jul 2023
Impact of the SGLT2-inhibitor empagliflozin on inflammatory biomarkers after acute myocardial infarction – a post-hoc analysis of the EMMY trial
Secondary analysis
Eur J Endocrinol5 Jul 2023
Mediation analysis of the testosterone treatment effect to prevent type 2 diabetes in the Testosterone for Prevention of Type 2 Diabetes Mellitus trial
Secondary analysis
Diabetes Obes Metab4 Jul 2023
Safety of sodium‐glucose cotransporter 2 inhibitors in elderly patients with type 2 diabetes: A meta‐analysis of randomized controlled trials
Meta-analysis
Cardiovasc Diabetol4 Jul 2023
The impact of fasting stress hyperglycemia ratio, fasting plasma glucose and hemoglobin A1c on in-hospital mortality in patients with and without diabetes: findings from the China acute myocardial infarction registry
Cohort study
J Diabetes Sci Technol4 Jul 2023
Selective Collection of Exhaled Breath Condensate for Noninvasive Screening of Breath Glucose
Research article
Lancet Diabetes Endocrinol3 Jul 2023
Safety and effectiveness of metformin plus lifestyle intervention compared with lifestyle intervention alone in preventing progression to diabetes in a Chinese population with impaired glucose regulation: a multicentre, open-label, randomised controlled trial
Randomized controlled trial
Diabetes Obes Metab3 Jul 2023
Prescription of guideline‐directed medical therapies in patients with diabetes and chronic kidney disease from the CURE‐CKD Registry, 2019‐2020
Cohort study
Diabetes Obes Metab3 Jul 2023
Contemporary trends in the utilization of second‐line pharmacological therapies for type 2 diabetes in the United States and the United Kingdom
Cohort study
Diabetes Obes Metab3 Jul 2023
The effects of empagliflozin on measured glomerular filtration rate and estimated extracellular and plasma volumes in patients with type 2 diabetes
Secondary analysis
J Diabetes Sci Technol3 Jul 2023
Economic Evaluations of mHealth Interventions for the Management of Type 2 Diabetes: A Scoping Review
Research article
JAMA Intern Med1 Jul 2023
Comparative Effects of Glucose-Lowering Medications on Kidney Outcomes in Type 2 Diabetes: The GRADE Randomized Clinical Trial
Secondary analysis
Diabetologia30 Jun 2023
Health and economic impact of improved glucose, blood pressure and lipid control among German adults with type 2 diabetes: a modelling study
Research article
Cardiovasc Diabetol30 Jun 2023
Effect of onset of type 2 diabetes on risks of cardiovascular disease and heart failure among new Zealanders with impaired glucose tolerance over 25 years: tapered-matched landmark analysis
Cohort study
Diabetes Res Clin Pract30 Jun 2023
Emotional distress and cardiovascular disease risk among participants enrolled in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) study
Cross-sectional study
Horm Res Paediatr30 Jun 2023
Virtual Learning and Youth-Onset Type 2 Diabetes during the COVID-19 Pandemic
Cohort study
Diabetes Obes Metab29 Jun 2023
A micro‐randomized pilot study to examine the impact of just‐in‐time nudging on after‐dinner snacking in adults with type 2 diabetes: A study protocol
Trial design
Diabetes Obes Metab29 Jun 2023
Diabetes remission in drug‐naïve patients with type 2 diabetes after dorzagliatin treatment: A prospective cohort study
Cohort study
Diabetes Obes Metab29 Jun 2023
All‐cause mortality and cardiovascular outcomes with sodium‐glucose Co‐transporter 2 inhibitors, glucagon‐like peptide‐1 receptor agonists and with combination therapy in people with type 2 diabetes
Cohort study
Diabetes Obes Metab29 Jun 2023
Mediators between canagliflozin and renoprotection vary depending on patient characteristics: Insights from the CREDENCE trial
Secondary analysis
Cardiovasc Diabetol29 Jun 2023
Non-linear association of atherogenic index of plasma with insulin resistance and type 2 diabetes: a cross-sectional study
Cross-sectional study
Diabetes Obes Metab28 Jun 2023
Baseline determinants of remission of type 2 diabetes in response to short‐term insulin‐based therapy: The pivotal role of beta‐cell function
Secondary analysis
BMJ Open Diabetes Res Care28 Jun 2023
Blood glucose, blood pressure, and cholesterol testing among adults with diabetes before and during the COVID-19 pandemic, USA, 2019 vs 2021
Cross-sectional study
Diabetes Res Clin Pract28 Jun 2023
Glucagon-like peptide-1 treatment reduces the risk of diabetes-type 2 related amputations: A cohort study in Denmark
Cohort study

All 4,758 Briefs in ExploreShowing Briefs 3,921–3,960 of 4,758, newest first